Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avantor, Inc. | 219,815 | reported | 08 May 2025 | tx 11+202,082−1,000 |
| Bellerophon Therapeutics, Inc. | 157,033 | reported | 31 Mar 2021 | tx 22+3,450,211 |
| AMGEN INC | 94,414 | reported | 28 Oct 2013 | tx 10+362,056−37,864 |
| Kite Pharma, Inc. | 0 | reported | 03 Oct 2017 | tx 13+96,184−146,184 |
2 purchases reported after at least 12 months of silence — most recent on 28 Apr 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2025 | GRANT_AWARD | Avantor, Inc. | 17,100 | 0.00 USD | |
| 28 Apr 2025 | PURCHASE | Avantor, Inc. | 8,091 | 12.81 USD | first after silence |
| 09 May 2024 | GRANT_AWARD | Avantor, Inc. | 8,477 | 0.00 USD | |
| 11 May 2023 | GRANT_AWARD | Avantor, Inc. | 9,808 | 0.00 USD | |
| 12 May 2022 | GRANT_AWARD | Avantor, Inc. | 6,693 | 0.00 USD | |
| 01 Apr 2022 | GRANT_AWARD | Avantor, Inc. | 1,215 | 0.00 USD | |
| 31 Mar 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 15,308 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Avantor, Inc. | 7,236 | 0.00 USD | |
| 21 Feb 2020 | GRANT_AWARD | Avantor, Inc. | 11,319 | 0.00 USD | |
| 23 Jan 2020 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 350,000 | 0.00 USD | |
| 21 May 2019 | GRANT_AWARD | Avantor, Inc. | 14,286 | 0.00 USD | |
| 21 May 2019 | EXERCISE | Avantor, Inc. | 117,857 | — | |
| 21 May 2019 | EXERCISE | Avantor, Inc. | 1,000 | 0.00 USD | deriv |
| 21 May 2019 | PURCHASE | Bellerophon Therapeutics, Inc. | 20,000 | 0.61 USD | |
| 23 Jan 2019 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 227,273 | 0.00 USD | |
| 25 Jan 2019 | PURCHASE | Bellerophon Therapeutics, Inc. | 714,286 | 0.70 USD | first after silence |
| 02 Apr 2018 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 99,010 | 0.00 USD | |
| 13 Sept 2017 | GIFT | Kite Pharma, Inc. | 635 | 0.00 USD | |
| 03 Oct 2017 | OTHER | Kite Pharma, Inc. | 1,807 | — | |
| 03 Oct 2017 | TENDER | Kite Pharma, Inc. | 67,932 | 180.00 USD | |
| 03 Oct 2017 | OTHER | Kite Pharma, Inc. | 7,000 | 129.13 USD | deriv |
| 03 Oct 2017 | OTHER | Kite Pharma, Inc. | 8,810 | 88.79 USD | deriv |
| 03 Oct 2017 | OTHER | Kite Pharma, Inc. | 10,000 | 120.77 USD | deriv |
| 03 Oct 2017 | OTHER | Kite Pharma, Inc. | 50,000 | 178.65 USD | deriv |
| 29 Sept 2017 | PURCHASE | Bellerophon Therapeutics, Inc. | 248,962 | — |